Effect and mechanism of AR-6 in experimental rheumatoid arthritis

Clinical and Experimental Medicine

Volumn 10, Issue 2, 2010, Pages 113-121

  Sun, Shi Xue ^a   Li, Yun Man ^a   Fang, Wei Rong ^a   Cheng, Peng ^a   Liu, Lifang ^a   Li, Fengwen ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Clematis chinensis Osbeck; Cytokines; Macrophages; Rheumatoid arthritis; Synoviocytes

Indexed keywords

ANTIRHEUMATIC AGENT; AR 6; FREUND ADJUVANT; NITRIC OXIDE; TRITERPENE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; ANTIINFLAMMATORY AGENT; AUTACOID; SAPONIN;

ADJUVANT ARTHRITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BLOOD LEVEL; CELL PROLIFERATION; CHINESE MEDICINE; CHRONIC DISEASE; CONTROLLED STUDY; DRUG EFFECT; EX VIVO STUDY; IN VITRO STUDY; MACROPHAGE; MALE; MEDIATOR RELEASE; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; RAT; RHEUMATOID ARTHRITIS; SCORING SYSTEM; SPRAGUE DAWLEY RAT; SYNOVIOCYTE; TRADITIONAL MEDICINE; ANIMAL; BLOOD; CHEMICALLY INDUCED DISORDER; CYTOLOGY; HOSPITALIZATION; IMMUNOLOGY; ORAL DRUG ADMINISTRATION; PATHOLOGY; SECRETION; SYNOVIAL FLUID; TREATMENT OUTCOME;

CLEMATIS CHINENSIS; RATTUS;

ADMINISTRATION, ORAL; ANIMALS; ANTI-INFLAMMATORY AGENTS; ARTHRITIS, RHEUMATOID; INFLAMMATION MEDIATORS; MACROPHAGES, PERITONEAL; MALE; NITRIC OXIDE; RATS; RATS, SPRAGUE-DAWLEY; SAPONINS; SEVERITY OF ILLNESS INDEX; SYNOVIAL FLUID; TREATMENT OUTCOME; TRITERPENES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77954662168     PISSN: 15918890     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10238-009-0075-8     Document Type: Article

References (34)

1. y SEFG (2004) Rheumatoid arthritis: regulation of synovial inflammation. Int J Biochem Cell Biol 36:372-378
2. Tak PPST, Daha MR, Kluin PM, Meijers KA, Brand R et al (1997) Analysis of the synovial cell infiltrate in early rheumatoid synovial tissue in relation to local disease activity. Arthritis Rheum 40:217-225
3. Choy EHPG (2001) Cytokine pathways and joint inflammation in rheumatoid arthritis. N Engl J Med 344:907-916
4. Mulherin DFO, Bresnihan B (1996) Synovial tissue macrophage populations and articular damage in rheumatoid arthritis. Arthritis Rheum 39:115-124
5. Sano HHT, Maier JA, Crofford LJ, Case JP, Maciag T et al (1992) In vivo cyclooxygenase expression in synovial tissues of patients with rheumatoid arthritis and osteoarthritis and rats with adjuvant and streptococcal cell wall arthritis. J Clin Invest 89:97-108
6. Miyasaka NHY (1997) Nitric oxide and inflammation arthritides. Life Sci 61:2073-2081
7. Farrell AJBD, Palmer RM, Moncada S (1992) Increased concentrations of nitrite in synovial fluid and serum samples suggest increased nitric oxide synthesis in rheumatic diseases. Ann Rheum Dis 51:1219-1222
8. Ueki YMS, Tominaga Y, Eguchi K (1996) Increased nitric oxide levels in patients with rheumatoid arthritis. J Rheumatol 23:230-236
9. Clair St EWWW, Lang T, Sanders L, Misukonis MA, Gilkeson GS et al (1996) Increased expression of blood mononuclear cell nitric oxide synthase type 2 in rheumatoid arthritis patients. J Exp Med 184:1173-1178
10. Mamani-Matsuda M, Kauss T, Abir Al-Kharrat J (2006) Therapeutic and preventive properties of quercetin in experimental arthritis correlate with decreased macrophage inflammatory mediators. Biochem Pharmacol doi:10.1016/j.bcp.2006.08.001 (Pubitemid 44604286)
11. Youn J, Cho M-L, Kim Y-J, Yun HS, Park S-H, Jin C-Z, Paik D-J, Kim H-Y (2005) New cyclooxygenase-2 inhibitor DFU regulates vascular endothelial growth factor expression in rheumatoid synoviocytes. Immunol Lett 96:219-224
12. Takahashi KKH, Kobayashi S, Kimura I, Terasawa K et al (1996) Antiproliferative effects of magnosalin derived from 'shin-I', a Japanese sinomedicine, on cultured synovial cells of MRL/1 and C57BL/6 J mice. Phytother Res 10:42-48
13. Warren JS (1990) Interleukins and tumor necrosis factor in inflammation. Crit Rev Clin Lab Sci 28:37-59
14. Firestein GS (2003) Evolving concepts of rheumatoid arthritis. Nature 423:356-361
15. Goronzy JJ (2005) Rheumatoid arthritis. Immunol Rev 204:55-73
16. Arend WP (1995) Inhibition of the production and effects of IL-1and TNF-a in RA. Arthritis Rheum 38:151-160
17. Choy EHS, Panayi GS (2001) Cytokine pathways and joint inflammation in rheumatoid arthritis. New Engl J Med 344:907-916
18. Takeuchi T, Nakanishi T et al (2007) Serum protein profile of rheumatoid arthritis treated with anti-TNF therapy (infliximab). J Chromatogr B 855:66-70
19. Hirano T (1992) The biology of interleukin-6. Chem Immunol 51:153-180
20. Tan PL, Farmiloe S, Yeoman S, Watson JD (1990) Expression of the interleukin 6 gene in rheumatoid synovial fibroblasts. J Rheumatol 17:1608-1612
21. Van't Hof RJHL, Wright PK, Ralston SH (2000) Nitric oxide is a mediator of apoptosis in the rheumatoid joint. Rheumatology 39:1004-1008
22. McCartney-Francis NAJ, Mizel DE, Albina JE, Xie QW, Nathan CF et al (1993) Suppression of arthritis by an inhibitor of nitric oxide synthase. J Exp Med 178:749-754
23. Simon LSW, Graham DY et al (1999) Anti-inflammatory and upper gastrointestinal effects of Celecoxib in rheumatoid arthritis: a randomized controlled trial. JAMA 282:1921-1928
24. Myers LKK, Postlethwaite AE et al (2000) The genetic ablation of cyclooxygenase 2 prevents the development of autoimmune arthritis. Arthritis Rheum 42:2687-2693
25. LG R (1999) Prostaglandins and bone: physiology and pathophysiology. Osteoarthritis Cartilage 7:419-421
26. Ma Y, Pope R (2005) The role of macrophages in rheumatoid arthritis. Curr Pharm Des 11:569-580
27. Folkman J (1995) Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1:27-31
28. Mamani-Matsuda M, Rambert J, Malvy D, Lejoly-Boisseau H, Daulouede S, Thiolat D et al (2004) Quercetin induces apoptosis of Trypanosoma brucei gambiense and decreases the proinflammatory response of human macrophages. Antimicrob Agents Chemother 48:924-929
29. Hammaker DSS, Firestein GS (2003) Signal transduction networks in rheumatoid arthritis. Ann Rheum Dis 62:86-89
30. Taylor PC (2003) Anti-cytokines and cytokines in the treatment of rheumatoid arthritis. Curr Pharm Des 9:1095-1106
31. Feldmann M (1996) The cytokine network in rheumatoid arthritis:definition of TNF alpha as a therapeutic target. J R Coll Physicians Lond 30:560-570
32. Tanaka Y (2001) The role of chemokines and adhesion molecules in the pathogenesis of rheumatoid arthritis. Drugs Today 37:477-484
33. Latha MR, Geetha T, Varalakshmi P (1998) Effect of Vernonia cinerea less flower extract in adjuvant-induced arthritis. Gen Pharmacol Res 31:601-606 (Pubitemid 28458932)
34. Di Giovine FS, Nuki G, Duff W (1988) Tumour necrosis factor in synovial exudates. Ann Rheum Dis 47:768-772